[Use of etofibrate in the treatment of patients with hyperlipidemia and arteriosclerosis obliterans of the legs].
Dembińska-Kieć
A
A
Kostka-Trabka
E
E
Grodzińska
L
L
Bieroń
K
K
Kedzior
A
A
Basista
M
M
Zmuda
A
A
Trabka
E
E
Sławiński
M
M
Czarnecka
B
B
D001162:Arteriosclerosis Obliterans / Q000188:drug therapy*; D002986:Clinical Trials as Topic; D002994:Clofibrate / Q000031:analogs & derivatives*; D002995:Clofibric Acid / Q000031:analogs & derivatives* / Q000627:therapeutic use; D005260:Female; D006801:Humans; D006949:Hyperlipidemias / Q000188:drug therapy*; D007866:Leg / Q000098:blood supply*; D008297:Male
C009746:etofibrate; D002995:Clofibric Acid; D002994:Clofibrate
Zastosowanie etofibratu w leczeniu chorych z hiperlipidemia i zarostowa miazdzyca tetnic kończyn dolnych.